Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Traumatic subdural effusion is a common complication of traumatic brain injury, especially after decompressive craniectomy (DC). For neurosurgeons, early diagnosis and timely treatment are particularly important, which can help improve patient prognosis and enhance quality of life.
Case Summary: A 47 year old male underwent DC for traumatic brain herniation. After surgery, he developed stubborn subdural effusion (SDE) on the contralateral side and underwent multiple subdural drilling and drainage surgeries, but only temporarily improved the patient's symptoms. After the final cranioplasty, the contralateral SDE completely disappeared. The patient did not experience any new contralateral neurological dysfunction, and the Glasgow prognostic score was 11 points (E4V1M6).
Conclusion: For neurosurgeons, accurate assessment of the condition is necessary when treating patients with stubborn SDE after DC surgery, and timely cranioplasty can be performed to avoid multiple surgeries. This is a safe and effective surgical method for treating traumatic subdural effusion.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11866272 | PMC |
| http://dx.doi.org/10.12998/wjcc.v13.i17.103350 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bilateral subdural hygromas following dural puncture.
BMJ Case Rep
August 2025
Department of Anaesthesiology, Our Lady of Lourdes Hospital, Drogheda, County Louth, Ireland.
A parturient reported a headache 20 hours following unintentional dural puncture during epidural placement for labour analgesia. It was positional, mild to moderate in severity with no focal neurological signs. Six days later, the headache became more severe.
View Article and Find Full Text PDFAdvances in Management of Subdural Effusion After Decompressive Craniectomy for Traumatic Brain Injury.
J Craniofac Surg
August 2025
Department of Neurosurgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University.
Subdural effusion is a common complication after decompressive craniectomy for traumatic brain injury. While many cases are asymptomatic and resolve with conservative management, some patients develop significant mass effect, leading to elevated intracranial pressure, midline shift, and clinical worsening, which may require surgery. Current treatment strategies vary widely, with no established consensus.
View Article and Find Full Text PDFHyperosmolar therapy for severe subarachnoid haemorrhage: a protocol for a multicentre prospective observational study (OSMO-SAH study).
BMJ Open
July 2025
Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, China
Introduction: Hyperosmolar therapy is crucial for the management of cerebral oedema and high intracranial pressure. Mannitol and hypertonic saline (HTS) at different concentrations are commonly used in clinical practice, but evidence of their use is mostly derived from studies about traumatic brain injury. The aim of this study was to evaluate the efficacy and safety of hyperosmolar therapy for severe aneurysmal subarachnoid haemorrhage (SAH).
View Article and Find Full Text PDFClinical features and prognostic factors of group B Streptococcus Meningitis in infants.
Brain Dev
July 2025
Department of Neurology, Children's Hospital of Chongqing Medical University, China; National Clinical Research Center for Child Health and Disorders, Chongqing, China; Ministry of Education Key Laboratory of Child Development and Disorders Chongqing, China; China International Science and Technolog
Purpose: To summarize the clinical features of group B streptococcus (GBS) meningitis in infants and identify the risk factors for poor prognosis.
Methods: The clinical data of 52 infants with GBS meningitis treated at Children's Hospital of Chongqing Medical University from January 2012 to December 2021 were retrospectively analyzed.
Results: A total of 48 infants (48/52, 92.
Unveiling Aducanumab's safety profile: A comprehensive pharmacovigilance analysis.
PLoS One
July 2025
Department of Cardiology, The Second People's Hospital of Baoshan, Baoshan, Yunnan, China.
Background: Aducanumab, a monoclonal antibody targeting amyloid-beta plaques, has been introduced as a pivotal therapeutic agent for Alzheimer's disease (AD). Although it offers promising benefits in the treatment of early-stage Alzheimer's disease, a thorough evaluation of its safety profile and potential adverse events (AEs) is essential to ensure patient safety.
Methods: This retrospective pharmacovigilance study analyzed data from the FDA Adverse Event Reporting System (FAERS) database to evaluate AEs associated with Aducanumab.